z-logo
Premium
Effects of minocycline on parameters of cardiovascular recovery after cardioplegic arrest in a rabbit Langendorff heart model
Author(s) -
Salameh Aida,
Halling Michelle,
Seidel Thomas,
Dhein Stefan
Publication year - 2015
Publication title -
clinical and experimental pharmacology and physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 103
eISSN - 1440-1681
pISSN - 0305-1870
DOI - 10.1111/1440-1681.12485
Subject(s) - minocycline , medicine , neuroprotection , malondialdehyde , pharmacology , anesthesia , cardiopulmonary bypass , context (archaeology) , hypothermia , ischemia , oxidative stress , cardiology , chemistry , antibiotics , biochemistry , biology , paleontology
Summary Pharmacological cardiac organ protection during cardiopulmonary bypass presents an opportunity for improvement. A number of different strategies have been established to minimize ischemia/reperfusion‐induced damage to the heart. Among these, cardioplegia with histidine‐tryptophan‐ketoglutarate solution and hypothermia are the most frequently used regimens. The antibiotic minocycline has been used in this context for neuroprotection. The aim of the current study was to evaluate whether the application of minocycline prior to cardioplegia exerts a protective effect on cardiac muscle. For this purpose, this study investigated six rabbit hearts with minocycline treatment (1  μ mol/L) and six without in a Langendorff model of 90 min cold cardioplegic arrest using Custodiol followed by a 30 min recovery phase. Histological analysis of cardiac muscle revealed that markers of apoptosis, oxidative and nitrosative stress were significantly lower in the minocycline group, whereas adenosine triphosphate ( ATP )‐ and malondialdehyde ( MDA )‐levels and O 2 ‐consumption were not affected by minocycline. Functionally, recovery of dP /dt (max) and dP /dt (min) was significantly faster in the minocycline group than in control. This leads to the conclusion that adding minocycline to the cardioplegic solution may improve left ventricular recovery after cardioplegic arrest involving reduced pro‐apoptotic effects.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom